18F-FDG PET/CT imaging in the workup of cardiac and pericardial masses

Bernhard, Benedikt; Gräni, Christoph

doi:10.1007/s12350-021-02539-4

Cited by 6 publications

(2 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…FDG images could help to better characterise the mass providing metabolic information: two recent trials [ 24 , 25 ] reported a good accuracy of FDG PET/CT in distinguishing benign from malignant mass. However, in case of malignancy, the FDG avidity varies depending on the histopathology [ 26 ], and sensitivity and specificity could be increased, thanks to morphological-CT features: indeed, the presence of irregular margins, necrosis, pericardial or pleural effusion, involvement of epicardium or adjacent tissue, are more likely correlated with malignant disease [ 27 ]. Intracardiac thrombus can occur after myocardial infarction, atrial fibrillation or mitral stenosis and it is correlated with severe morbidity due to embolic events.…”

Section: Clinical Applicationsmentioning

confidence: 99%

Actionable imaging findings in the daily PET/CT scenario

Mattana

Zanoni

Nanni

et al. 2023

Clin Transl Imaging

View full text Add to dashboard Cite

Background and aim The American College of Radiology (ACR) defines “actionable findings” the ones requiring a special communication between radiologists and referring clinicians, suggesting to organize their categorization in a three-degree scale on the basis of the risk for the patient to develop complications. These cases may fall in a grey-zone communication between different care figures with the risk of being underestimated or even not being considered at all. In this paper, our aim is to adapt the ACR categorization to the most frequent actionable findings encountered when reporting PET/CT images in a Nuclear Medicine Department, describing the most frequent and relevant imaging features and presenting the modalities of communication and the related clinical interventions that can be modulated by the prognostic severity of the clinical cases. Materials and methods We performed a descriptive, observational and critical analysis of the most relevant literature on the topic of “actionable findings”, in particular, starting from the reports of the ACR Actionable Reporting Work Group, we categorised and described, in a narrative review, the most relevant “actionable findings” encountered in the Nuclear Medicine PET/CT daily practice. Results To the best of our knowledge, to date there are no clear indications on this selective PET/CT topic, considering that the current recommendations target mainly radiologists and assume a certain level of radiological expertise. We resumed and classified the main imaging conditions under the term of “actionable findings” according to the corresponding anatomical districts, and we described their most relevant imaging features (independently of PET avidity or not). Furthermore, a different communication timing and strategy was suggested on the basis of the findings’ urgency. Conclusion A systematic categorization of the actionable imaging findings according to their prognostic severity may help the reporting physician to choose how and when to communicate with the referring clinician or to identify cases requiring a prompt clinical evaluation. Effective communication is a critical component of diagnostic imaging: timely receipt of the information is more important than the method of delivery.

show abstract

Section: Clinical Applicationsmentioning

confidence: 99%

Actionable imaging findings in the daily PET/CT scenario

Mattana

Zanoni

Nanni

et al. 2023

Clin Transl Imaging

View full text Add to dashboard Cite

show abstract

“…1 18 F-FDG PET/CT is helpful to differentiate a malignant from a benign cardiac tumor and to document treatment success. 2,3 Multimodality imaging is crucial for early noninvasive assessment of primary cardiac tumors, helps guiding further investigations, treatment decision and allows documentation of therapeutic success.…”

Section: Discussionmentioning

confidence: 99%

Multimodality imaging of cardiac B-cell lymphoma

Berto

Spano

Rhyner

et al. 2023

Journal of Nuclear Cardiology

Self Cite

View full text Add to dashboard Cite

Hybrid cardiovascular imaging. A clinical consensus statement of the european association of nuclear medicine (EANM) and the european association of cardiovascular imaging (EACVI) of the ESC

Caobelli,

Dweck,

Albano

et al. 2024

Eur J Nucl Med Mol Imaging

View full text Add to dashboard Cite

Hybrid imaging consists of a combination of two or more imaging modalities, which equally contribute to image information. To date, hybrid cardiovascular imaging can be performed by either merging images acquired on different scanners, or with truly hybrid PET/CT and PET/MR scanners. The European Association of Nuclear Medicine (EANM), and the European Association of Cardiovascular Imaging (EACVI) of the European Society of Cardiology (ESC) aim to review clinical situations that may benefit from the use of hybrid cardiac imaging and provide advice on acquisition protocols providing the most relevant information to reach diagnosis in various clinical situations.

show abstract

18F-FDG PET/CT imaging in the workup of cardiac and pericardial masses

Cited by 6 publications

References 15 publications

Actionable imaging findings in the daily PET/CT scenario

Actionable imaging findings in the daily PET/CT scenario

Multimodality imaging of cardiac B-cell lymphoma

Hybrid cardiovascular imaging. A clinical consensus statement of the european association of nuclear medicine (EANM) and the european association of cardiovascular imaging (EACVI) of the ESC

Contact Info

Product

Resources

About